复发性流产与种植失败中子宫自然杀伤细胞的数量与功能:系统综述与Meta分析
本系统综述与Meta分析纳入60项研究,比较复发性流产(RM)或反复种植失败(RIF)女性与对照的子宫自然杀伤细胞(uNK)。Meta分析显示RM和RIF女性子宫内膜CD56+ uNK水平显著升高,妊娠结局按uNK水平分层无差异,外周NK与uNK无显著相关性。
要点
- 按uNK水平分层的RM/RIF女性妊娠结局无差异,外周NK与uNK水平无显著相关性。
核心结论
- RM和RIF女性子宫内膜uNK水平显著升高,可能反映免疫环境紊乱导致种植和/或胎盘形成失败。
- 以pNK反映uNK行为的证据稀疏且临床用途有限。
- 测量uNK水平/活性可能更有用作为诊断工具,但需先建立标准化参考范围。
- 需进一步研究阐明潜在病理生理机制。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE、Web of Science和Cochrane Trials Registry自建库至2020年12月,按PRISMA指南筛选。
- 初检检出4636篇文章,最终纳入60篇文章进行系统综述。
- 对uNK水平、妊娠结局和uNK/pNK相关性进行Meta分析,对uNK活性进行叙述性综合。
- 偏倚风险采用ROBINS-I评估,发表偏倚采用Egger检验。
主要发现
- 按uNK水平分层的RM/RIF女性妊娠结局无差异,RM/RIF女性pNK与uNK水平无显著相关性。
- uNK活性研究变异大,多数研究显示RM女性抑制性受体表达降低、血管生成因子表达增加,细胞因子分泌结果大多不明确。
临床怎么用
- 测量uNK水平/活性可能更有用作为诊断工具,但需先建立标准化参考范围方可用于临床。
- 以pNK作为uNK行为指标的证据稀疏且临床用途有限。
局限性
- RM女性子宫内膜CD56+ uNK Meta分析异质性I²=88%。
- RIF女性子宫内膜CD56+ uNK Meta分析异质性I²=84%。
- uNK活性研究间变异大,细胞因子分泌结果大多不明确。
- 需进一步研究阐明潜在病理生理机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Uterine natural killer cells (uNK) are the most abundant lymphocytes found in the decidua during implantation and in first trimester pregnancy. They are important for early placental development, especially trophoblast invasion and transformation of the spiral arteries. However, inappropriate uNK function has been implicated in reproductive failure, such as recurrent miscarriage (RM) or recurrent implantation failure (RIF). Previous studies have mainly focussed on peripheral NK cells (pNK), despite the well-documented differences in pNK and uNK phenotype and function. In recent years, there has been an explosion of studies conducted on uNK, providing a more suitable representation of the immune environment at the maternal-foetal interface. Here, we summarize the evidence from studies published on uNK in women with RM/RIF compared with controls. OBJECTIVE AND RATIONALE: The objectives of this systematic review and meta-analysis are to evaluate: differences in uNK level in women with RM/RIF compared with controls; pregnancy outcome in women with RM/RIF stratified by high and normal uNK levels; correlation between uNK and pNK in women with RM/RIF; and differences in uNK activity in women with RM/RIF compared with controls. SEARCH METHODS: MEDLINE, EMBASE, Web of Science and Cochrane Trials Registry were searched from inception up to December 2020 and studies were selected in accordance with PRISMA guidelines. Meta-analyses were performed for uNK level, pregnancy outcome and uNK/pNK correlation. Narrative synthesis was conducted for uNK activity. Risk of bias was assessed by ROBINS-I and publication bias by Egger's test. OUTCOMES: Our initial search yielded 4636 articles, of which 60 articles were included in our systematic review. Meta-analysis of CD56+ uNK level in women with RM compared with controls showed significantly higher levels in women with RM in subgroup analysis of endometrial samples (standardized mean difference (SMD) 0.49, CI 0.08, 0.90; P = 0.02; I2 88%; 1100 women). Meta-analysis of CD56+ uNK level in endometrium of women with RIF compared with controls showed significantly higher levels in women with RIF (SMD 0.49, CI 0.01, 0.98; P = 0.046; I2 84%; 604 women). There was no difference in pregnancy outcome in women with RM/RIF stratified by uNK level, and no significant correlation between pNK and uNK levels in women with RM/RIF. There was wide variation in studies conducted on uNK activity, which can be broadly divided into regulation and receptors, uNK cytotoxicity, cytokine secretion and effect of uNK on angiogenesis. These studies were largely equivocal in their results on cytokine secretion, but most studies found lower expression of inhibitory receptors and increased expression of angiogenic factors in women with RM. WIDER IMPLICATIONS: The observation of significantly increased uNK level in endometrium of women with RM and RIF may point to an underlying disturbance of the immune milieu culminating in implantation and/or placentation failure. Further research is warranted to elucidate the underlying pathophysiology. The evidence for measuring pNK as an indicator of uNK behaviour is sparse, and of limited clinical use. Measurement of uNK level/activity may be more useful as a diagnostic tool, however, a standardized reference range must be established before this can be of clinical use.
引用
- Von Woon E, Greer O, Shah N, et al. Number and function of uterine natural killer cells in recurrent miscarriage and implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2022. PMID: 35265977. doi:10.1093/humupd/dmac006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。